Back to BNP Paribas Financial Markets BNP Paribas Financial Markets

GILD

Showing 8 of 31 quarters

Position history for BNP Paribas Financial MarketsBNP Paribas Financial Markets's holdings in Gilead Sciences, Inc.

Yes. BNP Paribas Financial Markets holds 2,536,332 shares of GILD (Gilead Sciences), worth $320.4M, as of its Q2 2026 13F filing. It increased the position by 569,394 shares (+29.0%) from Q1 2026. BNP Paribas Financial Markets has held GILD in every 13F on record since Q4 2018, 31 quarterly filings. GILD is 0.1% of BNP Paribas Financial Markets' reported 13F portfolio.

Current Value

$320.4M

Current Shares

2.5M

Total Value Change

+$82.6M

Total Shares Change

-301,093

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.5M
+28.9%
$320.4M0.1%$125.63
46
2026-Q1
Decreased
2M
-32.9%
$274.1M0.1%$137.68
0
2025-Q4
Increased
2.9M
+62.0%
$359.9M0.2%$120.57
54
2025-Q3
Decreased
1.8M
-10.2%
$200.9M0.1%$108.32
0
2025-Q2
Decreased
2M
-37.6%
$223.4M0.1%$107.45
0
2025-Q1
Decreased
3.2M
-9.0%
$361.6M0.2%$107.83
0
2024-Q4
Increased
3.5M
+25.0%
$327.6M0.2%$88.27
45
2024-Q3
Decreased
2.8M
-2.9%
$237.9M0.2%$79.45
0

Other major holders of GILD: BlackRock, Inc., Vanguard Group Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used